合作伙伴征集：2025全球手术机器人大会 报名：首届全球眼科大会 | 展位有限 报名：首届全球心血管大会 | 奖项评选 报名：首届全球骨科大会 | 奖项评选 2025年3月6日， 高德美（Galderma， SIX:GALD ）发布2024年年度财务报告。高德美 专注于皮肤科领域的 全球龙头企业，业务涵盖注射美容、皮肤护理和治疗性皮肤科产品。 2024年财务表现 业务增长驱动因素 注射美容 ：净销售额22.99亿美元，同比增长9.6%。其中，肉毒吉适（Dysport）和聚左旋乳酸填充剂 塑妍萃 （Sculptra）均实现了两位数增长。 产品和市场表现 净销售额 ：达到44.1亿美元（约320亿人民币），按固定汇率计算同比增长9.3%。 核心EBITDA（息税折旧摊销前利润） ：达到10.31亿美元，首次突破10亿美元大关，核心EBITDA利润 率为23.4%，较2023年提高30个基点。 债务杠杆率 ：截至2024年12月，杠杆率降至2.3倍，并成功发行了首笔瑞士债券。 皮肤护理 ：净销售额13.31亿美元，同比增长10.7%。Cetaphil和Alastin品牌表现强劲，尤其是在国际 市场。 治疗性皮肤科 ...

American Public Education, Inc. (NASDAQ:APEI) Q4 2024 Earnings Conference Call March 6, 2025 5:00 PM ET Company Participants Brian Prenoveau - IR Angela Selden - President and CEO Rick Sunderland - EVP and CFO Conference Call Participants Stephen Sheldon - William Blair Jasper Bibb - Truist Securities Operator Good afternoon, and thank you for standing by. My name is Kelvin, and I will be your conference operator today. At this time, I would like to welcome everyone to the American Public Education, Inc. re ...

Hippo Holdings Inc. (NYSE:HIPO) Q4 2024 Earnings Conference Call March 6, 2025 8:00 AM ET Company Participants Mark Olson - Director, Corporate Communications Richard McCathron - President and Chief Executive Officer Stewart Ellis - Chief Financial Officer Conference Call Participants Thomas McJoynt-Griffith - KBW Andrew Andersen - Jefferies Operator Hello, and welcome, everyone, to the Hippo's Fourth Quarter '24 Earnings Call. My name is Maxine, and I'll be coordinating the call today. [Operator Instructio ...

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2024 Earnings Conference Call March 6, 2025 8:30 AM ET Company Participants Allison Wey - SVP of IR, Corporate Communications John Shannon - CEO Steve Pieper - CFO Conference Call Participants Chase Knickerbocker - Craig-Hallum Oren Livnat - H.C. Wainwright Glen Santangelo - Jefferies David Amsellem - Piper Sandler Leland Gershell - Oppenheimer Mazahir Alimohamed - Leerink Partners Operator Good morning, and welcome to the Xeris Biopharma Fourth Quarter and Fu ...

For Immediate ReleaseChicago, IL – March 6, 2025 – Today, Zacks Equity Research Equity arePhillips 66 (PSX) , Marathon Petroleum (MPC) , Valero Energy (VLO) and Galp Energia (GLPEY) .Industry: Oil & Gas - Refining & MarketingLink: https://www.zacks.com/commentary/2425703/4-refining-marketing-stocks-that-can-weather-the-industry-stormThe Zacks Oil and Gas - Refining & Marketing industry faces challenges from volatile crude prices, regulatory pressures and rising operational costs. Seasonal Q4 refining margin ...

Core Viewpoint - The Zacks Oil and Gas - Refining & Marketing industry is currently facing challenges such as volatile crude prices, regulatory pressures, and rising operational costs, but it holds long-term growth potential due to strong demand for refined products and strategic investments in optimization and sustainability [1][4]. Industry Overview - The industry comprises companies that sell refined petroleum products and non-energy materials, with primary activities involving the processing of crude and other feedstocks into various refined products. Refining margins are highly volatile and influenced by factors such as inventory levels, demand, imports, and capacity utilization [2]. Trends Defining the Industry's Future - The industry is experiencing pressure on margins due to fluctuating crude prices, regulatory challenges, and seasonal weakness in refining margins. Geopolitical risks and rising operational costs are additional factors impacting profitability [3]. - Despite these challenges, the industry is well-positioned for long-term growth driven by strong global demand for refined products and operational efficiencies [4]. Cost Dynamics - Increasing operational costs from store expansions and wage pressures are affecting financial performance. Competitive pricing in non-fuel categories and slower recovery in discretionary spending further complicate the market landscape [5]. Industry Performance - The Zacks Oil and Gas - Refining & Marketing industry has underperformed compared to the broader Zacks Oil - Energy Sector and the S&P 500 over the past year, with a decline of 10.7% compared to a 3.3% increase in the sector and a 17.2% gain in the S&P 500 [10]. Current Valuation - The industry is currently trading at an EV/EBITDA ratio of 3.64X, significantly lower than the S&P 500's 17.27X and slightly below the sector's 4.21X. Over the past five years, the industry's EV/EBITDA has ranged from 1.80X to 6.96X, with a median of 3.63X [13]. Company Highlights - **Phillips 66**: A leading refiner with a refining capacity of 2.2 million barrels per day, expected to see 7.8% earnings growth in 2025 [15][16]. - **Marathon Petroleum**: An independent refiner with access to lower-cost crude, has a market capitalization of $45.6 billion and has consistently beaten earnings estimates [18][19]. - **Valero Energy**: The largest independent refiner in the U.S. with a capacity of 3.2 million barrels per day, has a strong earnings performance record [21]. - **Galp Energia**: A Portuguese integrated energy firm with a refining capacity in Portugal, has shown a 51.2% average earnings surprise over the past four quarters [22].

Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2024 Earnings Call March 4, 2025 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President, Marketing Stephen Gunstream - President and Chief Executive Officer Matt Lowell - Chief Financial Officer Conference Call Participants Matt Larew - William Blair Matthew Parisi - KeyBanc Capital Markets Mark Massaro - BTIG Matt Hewitt - Craig-Hallum Operator Thank you for standing by, and welcome to Alpha Teknova, Inc.'s Fourth Quarter and Full Year 2024 Earnings Conf ...

InfuSystem Holdings, Inc. (NYSE:INFU) Q4 2024 Results Conference Call March 4, 2025 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Kyle Bauser - B. Riley Securities Jim Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings, Inc. Reports fourth quarter and full ye ...

Financial Data and Key Metrics Changes - Adjusted EBITDA for 2024 was $127.6 million, up from $107.5 million in 2023, marking more than a doubling over the past two years [9] - The company anticipates total annual EBITDA of approximately $323 million, combining 2024 results with $195 million of incremental locked-in annual EBITDA under executed contracts [10] - The target for annual EBITDA is estimated to exceed $400 million, significantly higher than the previous target of just over $300 million [11] Business Line Data and Key Metrics Changes - Transtar reported Q4 revenue of $43.3 million and adjusted EBITDA of $19.4 million, compared to $44.8 million and $21.1 million in Q3 [26] - Jefferson generated $21.2 million in revenue and $11.1 million in adjusted EBITDA in Q4, up from $19.7 million and $11.8 million in Q3, excluding a one-time asset sale gain [29] - Long Ridge's EBITDA in Q4 was $9.9 million, down from $11.1 million in Q3, due to a planned maintenance outage [34] Market Data and Key Metrics Changes - The company is pursuing more new business opportunities than at any time since its spin-off, indicating a strong pipeline for growth [10] - The M&A market is described as the most active in years, with discussions on six opportunities representing well over $100 million of annual EBITDA [16][28] Company Strategy and Development Direction - The company plans to focus on substantial growth in 2025, with specific initiatives at Long Ridge, Repauno, and Jefferson [11][12][14] - Long Ridge's recent transactions are expected to enhance earnings significantly, allowing the company to capture 100% of the value creation [22] - The company is evaluating multiple products and counterparties at Jefferson, including crude oil, natural gas liquids, and renewables [41][46] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving substantial growth in 2025, driven by new contracts and business opportunities [11][12] - The anticipated increase in capacity payments and demand for power from hyperscalers is expected to positively impact Long Ridge's financials [36] - Management remains optimistic about the potential for M&A opportunities and the ability to finance acquisitions through debt markets [90] Other Important Information - The company has received approval for $300 million of tax-exempt debt, providing access to low-cost, long-term capital for construction projects [14] - The refinancing of corporate bonds and existing preferred stock is planned for the second quarter, aimed at reducing fixed charges and increasing cash flow [25][58] Q&A Session Summary Question: Expansion on new deals at Jefferson - Management is negotiating various products including crude oil, natural gas liquids, and renewables, with significant potential for growth [41][46] Question: Timing for Long Ridge's $160 million EBITDA - The full impact of the $160 million EBITDA from Long Ridge will be reflected in Q3, with partial contributions in Q1 and Q2 [48][50] Question: Update on Repauno permits and Phase 3 potential - Permits for the underground cavern are expected by the end of Q1, with Phase 3 potentially generating an incremental $100 million of EBITDA [62][64] Question: Transtar's organic growth target - Management remains confident in achieving a 15% organic growth rate, supported by anticipated increases in production levels [66][69] Question: M&A activity and financing - The company is evaluating several M&A opportunities and expects to announce a transaction within the next three months, with financing planned through debt markets [72][90]

Universal Health Services, Inc. (NYSE:UHS) Q4 2024 Earnings Call February 27, 2025 10:00 AM ET Company Participants Steve Filton - Executive Vice President and Chief Financial Officer Marc Miller - Chief Executive Officer Conference Call Participants Andrew Mok - Barclays Ben Hendrix - RBC Capital Markets Ann Hynes - Mizuho Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Joanna Gajuk - Bank of America Stephen Baxter - Wells Fargo Sarah James - Cantor Fitzgerald AJ Rice - UBS Michael Ha - Baird ...